Purple Biotech (PPBT) Prepaid Assets (2016 - 2026)
Purple Biotech's (PPBT) quarterly Prepaid Assets came in at $485000.0 in Q2 2026, up 23.1% year-over-year from $394000.0 in Q2 2025, and up 37.39% quarter-over-quarter from $353000.0 in Q1 2026.
Analysis
Purple Biotech (PPBT) Prepaid Assets (2016 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Prepaid Assets for 11 consecutive years, with $485000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 23.1% year-over-year to $485000.0 in Q2 2026; TTM through Jun 2026 was $485000.0, a 23.1% increase from a year earlier, with the FY2025 full-year figure at $292000.0, down 23.96% from the prior year.
- Prepaid Assets was $485000.0 for Q2 2026 at Purple Biotech, up from $353000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.4 million in Q1 2022 and troughed at $292000.0 in Q4 2025.
- A 5-year average of $763833.3 and a median of $516500.0 in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 57.96% in 2022 and plunged 67.1% in 2023, its largest moves.
- Over 5 years, Prepaid Assets stood at $1.1 million in 2022, then sank by 67.1% to $376000.0 in 2023, then gained by 2.13% to $384000.0 in 2024, then dropped by 23.96% to $292000.0 in 2025, then jumped by 66.1% to $485000.0 in 2026.
- The last three Prepaid Assets figures came in at $485000.0 (Q2 2026), $353000.0 (Q1 2026), and $292000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn |
| 10 | Purple Biotech | 291,843.46 | 291,843.46 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 485,000.00 |
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 638,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | 548,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 634,000.00 |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 1.13 Mn |